Similarly, Harlid and colleagues have identified that fibroblast growth factor 21 (FGF-21) and pancreatic prohormone (PPY) are associated with the risk of colon and rectal cancers, respectively, in plasma samples from asymptomatic patients and in a pre-diagnostic setting [54]. Here, PPY is linked to rectal cancer.